Merck breaks ground on new pharma manufacturing plant
Merck (NYSE:MRK) announced today that it began construction on a new pharmaceutical manufacturing plant at its Elkton, Virginia, site.| Pharmaceutical Processing World
Merck (NYSE:MRK) announced today that it began construction on a new pharmaceutical manufacturing plant at its Elkton, Virginia, site.| Pharmaceutical Processing World
By Sean Whooley | September 30, 2025| Pharmaceutical Processing World
Cardinal Health this week announced it began construction on its new pharmaceutical distribution center in Columbus, Ohio.| Pharmaceutical Processing World
AbbVie (NYSE:ABBV) announced that it began construction for a $70 million expansion of its bioresearch center (ABC) in Worcester, Massachusetts. The ABC in Worcester serves as a center of excellence for biologics R&D and manufacturing. AbbVie said its latest expansion comes as part of a plan to invest more than $10 billion in the U.S.… The post AbbVie invests $70M in U.S. biologics manufacturing, R&D expansion appeared first on Pharmaceutical Processing World.| Pharmaceutical Processing World
Amgen (Nasdaq: AMGN) recently announced it will invest $650 million to expand its biologics manufacturing facility in Juncos, Puerto Rico, a move expected to create nearly 750 jobs across construction and advanced manufacturing. The expansion will increase drug production capacity and integrate advanced technologies into operations, part of the company’s strategy to bolster its U.S.… The post Amgen to invest $650M in Puerto Rico biologics facility appeared first on Pharmaceutical Processi...| Pharmaceutical Processing World
by Michael Irving, Xylem In pharmaceutical and biopharmaceutical manufacturing, there is zero margin for error when it comes to process integrity and operator safety. Among the many variables that must be tightly controlled, pressure ranks high on the list. Overpressure or vacuum conditions can compromise not only equipment, but also batch sterility, production timelines, and… The post Advancing Pressure Protection in Biopharma: How Integrated Bypass Technology Elevates Single-Use Pump Desi...| Pharmaceutical Processing World
Fujifilm Biotechnologies recently announced it opened a $3.2 billion commercial-scale cell culture manufacturing site in Holly Springs, N.C., with eight 20,000-liter bioreactors and plans to double capacity. The facility is one of the largest commercial cell culture sites in North America, the company said. Phase one spans drug substance and drug product manufacturing, with finished… The post Fujifilm Biotechnologies opens $3.2B manufacturing site in North Carolina appeared first on Pharmac...| Pharmaceutical Processing World
Cardinal Health (NYSE:CAH) today announced plans for a new flagship forward distribution center in Indianapolis.| Pharmaceutical Processing World
By Sean Whooley | September 23, 2025| Pharmaceutical Processing World
Eli Lilly (NYSE:LLY) announced today that it plans to build a new $6.5 billion manufacturing facility at Generation Park in Houston, Texas. The planned next-generation synthetic medicine active pharmaceutical product (API) facility marks the second of four new sites Lilly plans to announce this year. It follows the announcement of a $5 billion manufacturing facility… The post Lilly to build new $6.5B API manufacturing plant in Texas appeared first on Pharmaceutical Processing World.| Pharmaceutical Processing World
Sai Life Sciences has opened Unit VI, a purpose-built veterinary API facility in Bidar, Karnataka, adjacent to the company’s flagship Unit IV API site. According to the company, the new plant is configured for stringent EHS practices and regulatory readiness to supply animal-health APIs at commercial scale. The unit will support global animal-health customers with… The post Sai Life Sciences opens dedicated veterinary-API unit alongside flagship Bidar site appeared first on Pharmaceutical...| Pharmaceutical Processing World
Eli Lilly (NYSE:LLY) announced today that it plans to build a $5 billion manufacturing facility in Goochland County, Virginia.| Pharmaceutical Processing World
Gilead Sciences (Nasdaq:GILD) announced that it broke ground on its new pharmaceutical development and manufacturing (PDM) technical development center (NTDC) in California. The facility, located at the company’s Foster City headquarters, comes as part of a $32 billion investment in U.S. innovation through 2030. Gilead expects the investment to generate more than $43 billion in… The post Gilead breaks ground on California manufacturing hub appeared first on Pharmaceutical Processing World.| Pharmaceutical Processing World
Eli Lilly (NYSE:LLY) announced today that it made a $4.5 billion investment to create the Lilly Medicine Foundry in Indiana.| Pharmaceutical Processing World
Eli Lilly's investment in capital expansion across therapeutic areas in the U.S. now totals more than $50 billion since 2020.| Pharmaceutical Processing World
Purdue University, Eli Lilly and Merck have launched the Young Institute Pharmaceutical Manufacturing Consortium.| Pharmaceutical Processing World
